Clinical	O
and	O
angiographic	B:C0002978
correlation	O
of	O
high	O
-	I:C0006560
sensitivity	I:C0006560
C-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
with	O
acute	O
ST	I:C1303258
elevation	I:C1303258
myocardial	I:C1303258
infarction	I:C1303258
.	O

Clinical	O
and	O
angiographic	O
correlation	O
of	O
high	B:C0006560
-	I:C0006560
sensitivity	I:C0006560
C-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
with	O
acute	O
ST	I:C1303258
elevation	I:C1303258
myocardial	I:C1303258
infarction	I:C1303258
.	O

Clinical	O
and	O
angiographic	O
correlation	O
of	O
high	O
-	I:C0006560
sensitivity	I:C0006560
C-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
with	O
acute	B:C1303258
ST	I:C1303258
elevation	I:C1303258
myocardial	I:C1303258
infarction	I:C1303258
.	O

Vascular	B:C0947751
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	B:C1155266
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	B:C0699748
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	B:C1963943
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	B:C0948089
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	B:C0948089
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	B:C0027051
infarction	I:C0027051
(	O
myocardial	O
infarction	I:C0027051
)	O
.	O

Vascular	O
inflammation	I:C0947751
and	O
associated	O
ongoing	O
inflammatory	O
responses	I:C1155266
are	O
considered	O
as	O
the	O
critical	O
culprits	O
in	O
the	O
pathogenesis	O
of	O
acute	O
atherothrombotic	O
events	O
such	O
as	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
(	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
)	O
and	O
myocardial	O
infarction	I:C0027051
(	O
myocardial	B:C0027051
infarction	I:C0027051
)	O
.	O

ST	B:C1536220
segment	I:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
(	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
)	O
is	O
considered	O
as	O
one	O
of	O
the	O
prominent	O
clinical	O
forms	O
of	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
.	O

ST	O
segment	I:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
(	O
segment	B:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
)	O
is	O
considered	O
as	O
one	O
of	O
the	O
prominent	O
clinical	O
forms	O
of	O
acute	O
coronary	I:C0948089
syndrome	I:C0948089
.	O

ST	O
segment	I:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
(	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
)	O
is	O
considered	O
as	O
one	O
of	O
the	O
prominent	O
clinical	O
forms	O
of	O
acute	B:C0948089
coronary	I:C0948089
syndrome	I:C0948089
.	O

Moreover	O
,	O
C-	B:C0006560
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	B:C0006560
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	B:C0001347
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	B:C3839560
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	B:C3839560
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	B:C0428528
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	B:C0005889
fluids	I:C0005889
reflects	O
chronic	O
inflammatory	I:C0021376
status	O
.	O

Moreover	O
,	O
C-	O
reactive	I:C0006560
protein	I:C0006560
(	O
C-	O
reactive	I:C0006560
protein	I:C0006560
)	O
is	O
an	O
important	O
acute	O
phase	I:C0001347
prsotein	I:C0001347
,	O
which	O
may	O
be	O
estimated	O
using	O
high	O
-	I:C3839560
sensitivity	I:C3839560
methods	I:C3839560
(	O
hs	O
-	I:C3839560
CRP	I:C3839560
)	O
,	O
and	O
its	O
elevated	O
level	O
in	O
body	O
fluids	I:C0005889
reflects	O
chronic	B:C0021376
inflammatory	I:C0021376
status	O
.	O

The	O
circulating	O
hs	B:C3839560
-	I:C3839560
CRP	I:C3839560
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	O
of	O
coronary	O
artery	I:C0010054
disease	I:C0010054
(	O
coronary	O
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
circulating	O
hs	O
-	I:C3839560
CRP	I:C3839560
level	B:C0428528
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	O
of	O
coronary	O
artery	I:C0010054
disease	I:C0010054
(	O
coronary	O
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
circulating	O
hs	O
-	I:C3839560
CRP	I:C3839560
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	B:C0021368
marker	O
of	O
coronary	O
artery	I:C0010054
disease	I:C0010054
(	O
coronary	O
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
circulating	O
hs	O
-	I:C3839560
CRP	I:C3839560
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	B:C0005516
of	O
coronary	O
artery	I:C0010054
disease	I:C0010054
(	O
coronary	O
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
circulating	O
hs	O
-	I:C3839560
CRP	I:C3839560
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	O
of	O
coronary	B:C0010054
artery	I:C0010054
disease	I:C0010054
(	O
coronary	O
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
circulating	O
hs	O
-	I:C3839560
CRP	I:C3839560
level	O
has	O
been	O
proposed	O
as	O
a	O
promising	O
inflammatory	O
marker	O
of	O
coronary	O
artery	I:C0010054
disease	I:C0010054
(	O
coronary	B:C0010054
artery	I:C0010054
disease	I:C0010054
)	O
.	O

The	O
present	O
study	B:C2603343
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	B:C3839560
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	B:C0428528
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	B:C0002978
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	B:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	B:C0035648
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	B:C0009566
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	B:C0027051
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	O
artery	I:C0010054
disease	I:C0010054
.	O

The	O
present	O
study	O
investigated	O
the	O
correlation	O
of	O
hs	O
-CRP	I:C3839560
level	O
with	O
clinical	O
and	O
angiographic	O
features	O
of	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
,	O
various	O
other	O
traditional	O
risk	O
factors	I:C0035648
,	O
complications	O
of	O
myocardial	O
infarction	I:C0027051
and	O
angiographically	O
significant	O
coronary	B:C0010054
artery	I:C0010054
disease	I:C0010054
.	O

Out	O
of	O
190	O
patients	O
with	O
segment	B:C1536220
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
that	O
were	O
analyzed	O
,	O
the	O
interval	O
between	O
symptom	O
onset	O
and	O
reperfusion	O
therapy	I:C0035124
(	O
window	O
period	O
)	O
varied	O
from	O
0.5	O
to	O
24	O
h	O
.	O

Out	O
of	O
190	O
patients	O
with	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
that	O
were	O
analyzed	B:C0936012
,	O
the	O
interval	O
between	O
symptom	O
onset	O
and	O
reperfusion	O
therapy	I:C0035124
(	O
window	O
period	O
)	O
varied	O
from	O
0.5	O
to	O
24	O
h	O
.	O

Out	O
of	O
190	O
patients	O
with	O
segment	O
elevation	I:C1536220
myocardial	I:C1536220
infarction	I:C1536220
that	O
were	O
analyzed	O
,	O
the	O
interval	O
between	O
symptom	O
onset	O
and	O
reperfusion	B:C0035124
therapy	I:C0035124
(	O
window	O
period	O
)	O
varied	O
from	O
0.5	O
to	O
24	O
h	O
.	O

The	O
hs	B:C3839560
-CRP	I:C3839560
value	O
was	O
found	O
to	O
be	O
higher	O
in	O
non-diabetic	O
patients	O
(	O
0.61	O
mg	O
/dl	O
)	O
compared	O
with	O
diabetic	O
patients	O
(	O
0.87	O
mg/dl	O
)	O
.	O

The	O
hs	O
-CRP	I:C3839560
value	O
was	O
found	O
to	O
be	O
higher	O
in	O
non-diabetic	O
patients	O
(	O
0.61	O
mg	O
/dl	O
)	O
compared	O
with	O
diabetic	B:C0011847
patients	O
(	O
0.87	O
mg/dl	O
)	O
.	O

Moreover	O
,	O
a	O
significant	O
correlation	O
between	O
hs	B:C3839560
-	I:C3839560
CRP	I:C3839560
and	O
hs	O
-	I:C3827339
troponin	I:C3827339
T	I:C3827339
was	O
also	O
recorded	O
(	O
P<	O
0.001	O
)	O
.	O

Moreover	O
,	O
a	O
significant	O
correlation	O
between	O
hs	O
-	I:C3839560
CRP	I:C3839560
and	O
hs	B:C3827339
-	I:C3827339
troponin	I:C3827339
T	I:C3827339
was	O
also	O
recorded	O
(	O
P<	O
0.001	O
)	O
.	O

However	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
mean	O
hs	B:C3839560
-CRP	I:C3839560
values	O
in	O
patients	O
with	O
or	O
without	O
mortality	O
.	O

It	O
is	O
considered	O
that	O
the	O
present	O
study	B:C2603343
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	O
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	O
for	O
this	O
harmful	O
disease	O
.	O

It	O
is	O
considered	O
that	O
the	O
present	O
study	O
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	B:C0004153
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	O
for	O
this	O
harmful	O
disease	O
.	O

It	O
is	O
considered	O
that	O
the	O
present	O
study	O
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	O
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	B:C0087111
for	O
this	O
harmful	O
disease	O
.	O

It	O
is	O
considered	O
that	O
the	O
present	O
study	O
will	O
increase	O
the	O
understanding	O
of	O
atherosclerosis	O
in	O
general	O
and	O
may	O
also	O
have	O
clinical	O
applications	O
in	O
the	O
targeting	O
of	O
therapy	O
for	O
this	O
harmful	O
disease	B:C0012634
.	O

